These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12170133)

  • 61. Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics.
    Summerton J; Riedesel M; Laeyendecker O; Gaydos C; Maldeis NE; Hardick A; Morrow RA; Quinn TC
    Clin Vaccine Immunol; 2007 Dec; 14(12):1545-9. PubMed ID: 17913866
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2-based immunoassays for HSV-2 seroprevalence studies.
    García-Corbeira P; Hogrefe W; Aguilar L; García-de-Lomas J; Gil A; Bayas JM; Vilella A; Dal-Ré R
    J Med Virol; 1999 Dec; 59(4):502-6. PubMed ID: 10534733
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genital herpes. Type-specific antibodies for diagnosis and management.
    Ashley RL
    Dermatol Clin; 1998 Oct; 16(4):789-93, xiii-xiv. PubMed ID: 9891682
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serologic Screening for Genital Herpes: An Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Feltner C; Grodensky C; Ebel C; Middleton JC; Harris RP; Ashok M; Jonas DE
    JAMA; 2016 Dec; 316(23):2531-2543. PubMed ID: 27997660
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G.
    Morrow RA; Friedrich D; Krantz E; Wald A
    Sex Transm Dis; 2004 Aug; 31(8):508-15. PubMed ID: 15273585
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HSV-2 serologic testing in an HMO population: uptake and psychosocial sequelae.
    Richards J; Scholes D; Caka S; Drolette L; Magaret AM; Yarbro P; Lafferty W; Crosby R; Diclemente R; Wald A
    Sex Transm Dis; 2007 Sep; 34(9):718-25. PubMed ID: 17471113
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of immunoassays for differentiation of herpes simplex virus type 1 and 2 antibodies.
    Qutub MO; Klapper PE; Vallely PJ; Cleator GM; Mandall D
    Saudi Med J; 2006 Jun; 27(6):788-93. PubMed ID: 16758036
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa.
    Gopal R; Gibbs T; Slomka MJ; Whitworth J; Carpenter LM; Vyse A; Brown DW
    J Virol Methods; 2000 Jun; 87(1-2):71-80. PubMed ID: 10856754
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood.
    Laderman EI; Whitworth E; Dumaual E; Jones M; Hudak A; Hogrefe W; Carney J; Groen J
    Clin Vaccine Immunol; 2008 Jan; 15(1):159-63. PubMed ID: 18003814
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy.
    Arvaja M; Lehtinen M; Koskela P; Lappalainen M; Paavonen J; Vesikari T
    Sex Transm Infect; 1999 Jun; 75(3):168-71. PubMed ID: 10448394
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression and characterization of the soluble form of recombinant mature HSV-2 glycoprotein G for use in anti-HSV-2 IgG serodiagnostic immunoassay.
    Jun W; Hu R; Hyland L; Crandall D; Ramachandran P; Pangarkar C; Sivaraman S; Haghiri B
    J Virol Methods; 2018 Feb; 252():65-69. PubMed ID: 29104048
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recombinant glycoprotein G analog for determination of specific immunoglobulins to herpes simplex virus type 2 by ELISA.
    Korshun L; Vudmaska M; Moysa L; Kovtonjuk G; Mikhalap S; Ganova L; Spivak N
    J Virol Methods; 2013 Dec; 194(1-2):67-73. PubMed ID: 23933396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections.
    Risinger C; Sørensen KK; Jensen KJ; Olofsson S; Bergström T; Blixt O
    ACS Infect Dis; 2017 May; 3(5):360-367. PubMed ID: 28238255
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
    Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
    Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.
    Slomka MJ
    Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An evidence based approach to testing for antibody to herpes simplex virus type 2.
    Copas AJ; Cowan FM; Cunningham AL; Mindel A
    Sex Transm Infect; 2002 Dec; 78(6):430-4. PubMed ID: 12473804
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An evaluation of near patient tests for detecting herpes simplex virus type-2 antibody.
    Saville M; Brown D; Burgess C; Perry K; Barton S; Cowan F; Palu G; Mengoli C
    Sex Transm Infect; 2000 Oct; 76(5):381-2. PubMed ID: 11141856
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HSV type specific antibody tests: patients are ready, are clinicians?
    Ashley RL; Corey L
    Genitourin Med; 1997 Aug; 73(4):235-6. PubMed ID: 9389940
    [No Abstract]   [Full Text] [Related]  

  • 79. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial.
    Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R
    Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection.
    Morrow R; Friedrich D
    Clin Microbiol Infect; 2006 May; 12(5):463-9. PubMed ID: 16643524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.